Evidence map›Paper›PMID 40521216›Full record

Article3 Biotech2025

Polar microalgae-based nanoparticles: a next-generation strategy for cancer treatment.

Gülcan Ayşin Karaca, Özgür Cem Erkin, Benan İnan, Didem Balkanlı

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gülcan Ayşin KaracaDepartment of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Davutpasa Campus, Esenler, 34220 Istanbul, Türkiye.ORCID 0000-0003-3905-851X
Özgür Cem ErkinDepartment of Bioengineering, Faculty of Engineering, Adana Alparslan Turkes Science and Technology University, 01250 Adana, Türkiye.ORCID 0000-0001-9818-3447
Benan İnanDepartment of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Davutpasa Campus, Esenler, 34220 Istanbul, Türkiye.ORCID 0000-0002-2315-3099
Didem BalkanlıDepartment of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Davutpasa Campus, Esenler, 34220 Istanbul, Türkiye.ORCID 0000-0003-2483-7617

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polar microalgae are one of the species that produce valuable bioactives and effective antioxidants as a metabolic adaptation mechanism to tolerate harsh conditions of polar regions. In this manner, evaluating bioactive compounds obtained from polar microalgae against cancer cells is expected to offer promising outcomes. Among these bioactive compounds, the flavonoids found in microalgae stand out with their anticancer activity. In this study, flavonoid-rich extracts of

Indexed as

Anti-cancer activityC. pyrenoidosaC. sorokinianaNanoparticlePolar microalgae

Identifiers

PMID40521216
PMCPMC12158890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.